Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.

Key PointsNovartis recently announced bad news for its Lp(a)-lowering drug, pelacarsen.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Finance & Markets

More from Monday 14 September →